2 active not recruiting, 2 recruiting, 1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow NUT Carcinoma: new trials by email Literature Review of NUT Carcinoma trials Research Report on NUT Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An International Study on Pediatric Patients With Rare Tumors. Paraganglioma/ Phaeochromocytoma, Melanoma and Other Malignant Neoplasms of Skin | Recruiting | Azienda Ospedaliera di Padova | 6250 | 2025-01-25 | 2025-07-18 | |
| A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors Tumor and HLA Profiling - Head and Neck Cancer, Cervical Cancer | Active not recruiting | TScan Therapeutics, Inc. | 1150 | 2023-06-26 | 2025-11-17 | |
| Biology of Young Lung Cancer Study: The YOUNG LUNG Study Data and Specimen Collection - Non Small Cell Lung Cancer, Small Cell Lung Carcinoma | Recruiting | Dana-Farber Cancer Institute | 500 | 2023-01-01 | 2026-10-19 | |
| Multicenter Retrospective Cohort of Pulmonary NUT Carcinoma Standard-of-care anticancer treatment (retrospective) - NUT Carcinoma | Active not recruiting | Three Gorges Hospital of Chongqing University | 150 | 2023-01-01 | 2026-03-09 | |
| Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies EP31670 - Castrate Resistant Prostate Cancer, NUT Carcinoma | Phase 1 | Unknown | Epigenetix, Inc. | 75 | 2022-12-21 | 2025-01-14 |
| BI 894999 First in Human Dose Finding Study in Advanced Malignancies BI 894999 - Neoplasms, NUT Carcinoma | Phase 1 | Completed | Boehringer Ingelheim | 174 | 2015-07-08 | 2024-04-15 |
Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma (1) · Adrenal Cortex Neoplasms (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Esthesioneuroblastoma, Olfactory (1) · Gastrointestinal Stromal Tumors (1) · Head and Neck Neoplasms (1) · Leukemia, Myelomonocytic, Chronic (1) · Melanoma (1) · Mesothelioma (1) · Nasopharyngeal Carcinoma (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Pleuropulmonary blastoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Hemic and Lymphatic Diseases (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2)
BI 894999 (1) · NEO2734 (1) · Retrospective Studies (1) · Specimen Handling (1)
Azienda Ospedaliera di Padova (1) · Boehringer Ingelheim (1) · Dana-Farber Cancer Institute (1) · Epigenetix, Inc. (1) · TScan Therapeutics, Inc. (1) · Three Gorges Hospital of Chongqing University (1)
United States (4) · Belgium (1) · China (1) · France (1) · Germany (1) · Italy (1) · South Korea (1) · Spain (1)
Dawn Pinchasik, MD (1) · Gianni Bisogno, MD (1) · Judy Chiao, MD (1) · Pasi A Janne, MD, PhD (1)
2015 (1)